CClinicalTrials.gg
CompletedNCT07765381Updated Aug 14, 2026

A Clinical Trial to Evaluate the Effects of a Supplement on Symptoms Associated With Hormone Imbalance

An interventional study of Hello Burn, Balance Supplement in Hormone Imbalance, Thyroid Hormone Imbalance and Low Energy, sponsored by Love Wellness. Completed at 1 site in United States. Open to participants aged 25 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by Love Wellness · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
25 Years and older
Sex
All
01

Study summary

This study evaluates the effects of the Love Wellness Hello Burn, Balance supplement on symptoms associated with hormone imbalance, as measured by energy levels and healthy eating choices and habits. The trial is a single-arm, open-label, virtual study conducted over 4 weeks, in which all 40 enrolled participants will take the test product daily.

Participants will complete self-reported questionnaires at Baseline, after First Use (within 1-3 hours of use), and at Weeks 1, 2, 3, and 4 to assess changes in symptoms associated with hormonal imbalance, energy levels, healthy eating choices and habits, metabolism, and overall product efficacy.

02

Conditions studied

  • Hormone Imbalance
  • Thyroid Hormone Imbalance
  • Low Energy
  • Metabolic Symptoms
  • Unhealthy Eating Habits
03

Who can participate

Ages eligible
25 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Be female
  • Be aged 25 or over
  • Has in the past 4 weeks experienced issues regarding all of the following: difficulty making healthy eating choices and habits, hormonal-driven challenges with healthy eating choices and habits, self-perceived slow metabolism, and low energy
  • Generally healthy - does not live with any uncontrolled chronic disease
  • If taking oral over-the-counter supplements or herbal remedies targeted at hormone balance or energy, has been consistently taking these for at least 3 months prior to starting the study and is willing to maintain this routine for the study duration
  • Willing to refrain from introducing any products or any new forms of prescription medication or supplements that target hormone balance or energy for the study duration
  • Willing to maintain their diet, sleep schedule, and activity level for the duration of the study
  • Not currently partaking in another research study and will not be partaking in any other research study for the next 4 weeks and at any point during this study's duration
  • Resides in the United States

Exclusion criteria

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
  • Anyone currently taking a prescription thyroid treatment (like levothyroxine)
  • Anyone with known severe allergic reactions
  • Anyone with any allergies or sensitivities to any of the study product ingredients
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
  • Anyone diagnosed with diabetes (type I or type II)
  • Anyone unwilling to follow the study protocol
  • Has changed birth control in the past 3 months
  • Anyone planning to undergo any surgeries or invasive treatments during the study duration
  • Anyone who has had any major illness in the last 3 months
  • Anyone with a history of substance abuse
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Hello Burn, Balance Supplement

    Dietary Supplement: Hello Burn, Balance Supplement

Interventions

  • Dietary supplementHello Burn, Balance Supplement

    All participants take 2 capsules of the Love Wellness Hello Burn, Balance supplement once daily in the morning with a glass of water during the first meal of the day for 4 weeks. The supplement contains selenium (as L-selenomethionine) 55 mcg, chromium (as chromium polynicotinate) 35 mcg, Hello Burn Blend (L-carnitine tartrate, organic green tea leaf powder) 1250 mcg, hypromellose capsule, microcrystalline cellulose, and magnesium stearate.

05

What researchers measure

Primary outcomes

  1. Change in Symptoms Associated with Hormone Imbalance

    Assessed via self-reported questionnaire measuring participant-perceived symptoms associated with hormonal imbalance

    Time frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4

Secondary outcomes

  1. Change in Energy Levels

    Assessed via self-reported questionnaire measuring participant-perceived energy levels

    Time frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4

  2. Change in Healthy Eating Choices

    Assessed via self-reported questionnaire measuring participant-perceived healthy eating choices and including stress eating

    Time frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4

  3. Change in Perception of Metabolism

    Assessed via self-reported questionnaire measuring participant-perceived metabolic rate

    Time frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4

  4. Product Efficacy Perception

    Assessed via self-reported questionnaire measuring participant perception of the test product's overall efficacy

    Time frame: Baseline, First Use (within 1-3 hours of use), Week 1, Week 2, Week 3, and Week 4

06

Study locations

1 site
  • Citruslabs
    Las Vegas, Nevada 89101, United States
07

Registry details

Key details

Study ID
NCT07765381
Lead sponsor
Love Wellness
Collaborators
Citruslabs
Responsible party
Sponsor
First posted
Aug 14, 2026
Start date
Feb 24, 2025
Primary completion
Apr 17, 2025
Completion
Apr 17, 2025
Last update
Aug 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion